Jianwei Wang mainly focuses on Virology, Coronavirus, Immunology, Innate immune system and Interferon. Jianwei Wang interconnects Nasopharyngeal aspirate, Respiratory tract infections and Pathogen in the investigation of issues within Virology. His Coronavirus study integrates concerns from other disciplines, such as Viral entry, Antibody, Betacoronavirus and Plasma protein binding.
In his research, Intensive care unit, Viral pneumonia, Medical record, GenBank and Sequence is intimately related to Middle East respiratory syndrome, which falls under the overarching field of Betacoronavirus. His Immunology study incorporates themes from Recombinant DNA and Pneumonia. His research in Pneumonia intersects with topics in Epidemiology and Lung.
His main research concerns Virology, Virus, Immunology, Antibody and Coronavirus. His Virology study combines topics from a wide range of disciplines, such as Respiratory tract infections, Recombinant DNA, Antigen and Severe acute respiratory syndrome coronavirus 2. The study incorporates disciplines such as Genotype and Pneumonia in addition to Virus.
His Immunology study combines topics in areas such as Human metapneumovirus, Respiratory disease and Internal medicine, Disease. His Internal medicine study focuses on Epidemiology in particular. His research ties Plasma protein binding and Coronavirus together.
Jianwei Wang spends much of his time researching Virology, Severe acute respiratory syndrome coronavirus 2, Coronavirus disease 2019, Coronavirus and Antibody. His study in Virology is interdisciplinary in nature, drawing from both Betacoronavirus and Pneumonia. His study explores the link between Betacoronavirus and topics such as Middle East respiratory syndrome that cross with problems in Viral pneumonia, GenBank, Sequence and Respiratory disease.
His Coronavirus research integrates issues from Immunoglobulin light chain, TaqMan, Peptide sequence and Monoclonal antibody. His Antibody research includes themes of Internal medicine and Antigen. His work on Clinical trial, Intensive care unit, Retrospective cohort study and Medical record as part of general Internal medicine study is frequently linked to Informed consent, therefore connecting diverse disciplines of science.
Jianwei Wang mostly deals with Virology, Coronavirus, Pneumonia, Coronavirus disease 2019 and Betacoronavirus. His work deals with themes such as Innate immune system, Antibody and Signal transduction, which intersect with Virology. The various areas that Jianwei Wang examines in his Coronavirus study include Inflammation, Immunology, Immune system, Chemokine and Proinflammatory cytokine.
Pneumonia connects with themes related to Epidemiology in his study. His Betacoronavirus research is multidisciplinary, relying on both Virus and Middle East respiratory syndrome. His studies in Middle East respiratory syndrome integrate themes in fields like Respiratory disease, Medical record, GenBank, Viral pneumonia and Intensive care unit.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang;Yeming Wang;Xingwang Li;Lili Ren.
The Lancet (2020)
Correction: Corrigendum: The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes
Jing Guo;Fengming Huang;Jun Liu;Yu Chen.
Scientific Reports (2016)
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV.
Xiuyuan Ou;Yan Liu;Xiaobo Lei;Pei Li.
Nature Communications (2020)
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
Chaolin Huang;Lixue Huang;Lixue Huang;Yeming Wang;Xia Li.
The Lancet (2021)
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study
Ting Shi;David A. McAllister;Katherine L. O'Brien;Eric A. F. Simoes.
The Lancet (2017)
Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)
Li Guo;Lili Ren;Siyuan Yang;Meng Xiao.
Clinical Infectious Diseases (2020)
Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study.
Li Li Ren;Ye Ming Wang;Zhi Qiang Wu;Zi Chun Xiang.
Chinese Medical Journal (2020)
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial.
Ling Li;Wei Zhang;Yu Hu;Xunliang Tong.
Activation and evasion of type I interferon responses by SARS-CoV-2.
Xiaobo Lei;Xiaojing Dong;Ruiyi Ma;Wenjing Wang.
Nature Communications (2020)
Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients.
Zhuo Zhou;Zhuo Zhou;Lili Ren;Li Zhang;Jiaxin Zhong;Jiaxin Zhong.
Cell Host & Microbe (2020)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: